Sergio Traversa - 15 Dec 2023 Form 4 Insider Report for RELMADA THERAPEUTICS, INC. (RLMD)

Role
Chief Executive Officer, Director
Signature
/s/ Sergio Traversa
Issuer symbol
RLMD
Transactions as of
15 Dec 2023
Net transactions value
$0
Form type
4
Filing time
19 Dec 2023, 17:28:56 UTC
Previous filing
30 May 2023
Next filing
31 Jan 2024
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction RLMD Stock Option (right to buy) Award $0 +183,881 $0.000000 183,881 15 Dec 2023 Common Stock 183,881 $2.48 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The options vest in 16 equal quarterly installments commencing on March 15, 2024.